Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lattice Semiconductor Corporation Common Stock (LSCC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Lattice Semiconductor Corporation Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Lattice Semiconductor Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Lattice Semiconductor Corporation Common Stock trades at $106.68 (market cap $16.33B), while Vir Biotechnology Inc. Common Stock trades at $10.52 (market cap $1.76B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 9.3× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lattice Semiconductor Corporation Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

LSCCVIR
Market Cap
$16.33B$1.76B
Volume
1,986,6702,764,948
Sector
TechnologyHealth
52-Week High
$155.27$11.78
52-Week Low
$61.73$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$16.20B$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lattice Semiconductor Corporation Common Stock

Lattice Semiconductor (LSCC) trades at $121.15, down 1.38% today, with a bullish technical signal from moving averages. The company shows strong revenue growth projections from $523M in 2025 to $651M in 2026, though current valuation metrics remain elevated with a P/E of 504.2. Recent news highlights leadership in AI infrastructure security and new FPGA product launches, supported by overwhelmingly positive analyst sentiment with 88% buy ratings.

LSCC presents growth potential through AI-driven semiconductor demand and expanding product portfolio, but faces risks from high valuations and competitive pressures. The consensus price target of $162.14 suggests 34% upside, though investors should monitor execution on projected margin expansion from 0.58% to 5.57% net profit margin.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LSCC

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Lattice Semiconductor Corporation Common Stock

Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.

Read more on LSCC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →